Resources


Learn more about our approach to sustainability and our outcomes by exploring these global policies, reports, videos, infographics and other materials.


Annual sustainability reporting


Our Annual sustainability reporting section includes supplementary and complementary information to our annual Sustainability report.
Here you can find more in-depth information on our Access to Healthcare Strategy, Employee well-being, Supply chain, GHG emissions, etc.

 

2017

This is our third sustainability report, and it describes our progress and challenges in 2017. The content of this report is based on those sustainability issues deemed material through formal stakeholder engagement and analysis.


This summary is meant to provide employees with the essential information on our sustainability strategy and initiatives in 2017.


Here you can see metrics for each of AstraZeneca's sustainability priorities - Access to Healthcare, Environmental Protection, Ethics & Transparency and Foundations -  from 2015, 2016, and 2017.


Bureau Veritas independently verified sustainability information of the 2017 Annual Report.


This graphic shows the impacts HHA has had on people’s lives in numbers, in terms of trained healthcare workers, healthcare facilities activated, etc.


Bureau Veritas independently verified the target statuses of the 2017 Sustainability Report.


This graphic shows issues that are material for AstraZenenca and its diverse stakeholders. Each issue is categorized into one of our 4 priority areas - Access to Healthcare, Environmental Protection, Ethics & Transparency, and Foundations.


This graphic shows how AstraZeneca is responding to non-communicable diseases (NCDs) across various countries.


This graphic shows how each region across the world is participating in employee Global Health & Well-Being Programmes. These programmes include four essential health activities - Physical activity, Healthy drinking & eating, Stress/pressure management, and Tobacco cessation.


This graphic gives details on hypertension (high blood pressure), its effects on patients and the economy, and its prevalence in Africa.


This graphic explains how we are working to reduce GHG emissions, across the three main parts of our value chain - Upstream, Operations, and Downstream.


This graphic explains how our pre-clinical animal studies tests are run, through a process called the 3Rs (Replacement, Refinement, and Reduction).


This graphic details our efforts to drive and foster a responsible supply chain. We do this through quality audits, environmental assessments, and third-party risk management assessments.


This document outlines the history of HHA, its milestones in providing access to healthcare, and importance in a region burdened by hypertension (high blood pressure).  


2016

2015

Global policies and positions

Our Global policies and positions guide how we run our business, and set ethical expectations for our employees and our partners.


This policy defines the principles, behaviours and ethical standards behind our global R&D efforts. It covers topics such as: clinical trials, patient safety, privacy of information, genomic information, GMOs, animals in research, Nagoya protocol, etc.


Our Code of Ethics is the foundation for our sustainability strategy. It defines our values at work and guides everything we do, ensuring that we deliver life-changing medicines in a responsible way.


Sets out requirements for processing personal data and aligns with and, in some cases, exceeds the requirements of applicable laws and regulations. We value the personal data entrusted to us, and we are committed to collecting, using, retaining, and disclosing personal data in a fair, transparent and secure way.


This document provides the minimum standards for the identification and assessment of ergonomic hazards and other human factors. Ergometry refers designing workplaces for employees' physiological and psychological needs.


This Policy describes what is required to meet AstraZeneca’s (“AZ’s”) commitment to operate ethically in our business and personal interactions with third parties. This includes patients, external stakeholders, and other third parties, such as the media, vendors, suppliers, partners, etc.


This is a guide for third parties working at AstraZeneca. It outlines what we believe is required to “do the right thing” and the process we follow to ensure that Third Parties embrace similar ethical standards to our own.


This is our first Gender Pay Gap Report. In it, we provide gender pay information for AstraZeneca in the United Kingdom and outline our plans for supporting women, as well as continuing to improve the diversity of our company globally.


This document sets out AstraZeneca’s ethical business expectations of Third Parties with which it interacts to ensure their conduct is consistent with our own.


This statement details how AstraZeneca respects the rights of all stakeholders - including employees, patients, suppliers, communities, and the environment. We are committed to treating everyone with dignity and respect and to ensuring that third parties we work with do the same.


This statement describes our commitment to expand access to healthcare through intellectual property (IP). AstraZeneca sees IP as a driver for innovation that will lead to the discovery of new medicines.


This document intends to make our tax approach transparent by detailing our governance, risk management, compliance, tax planning, dealings with tax authorities, etc.


As a responsible healthcare company, we make it a priority to effectively manage the risks associated with pharmaceuticals in the environment (PIE).


This document has information explaining our Pricing Policy and our commitment of making our medicines available and affordable. Some of our flexible approaches to pricing include: Early Access Programs, Tiered Pricing, and Patient Assistance. 


This document outlines workplace noise and vibration hazards, with the objective of protecting people from health effects associated with poor management of these issues.


Code of Ethics

Our Code of Ethics is the foundation for our sustainability strategy. It defines our values at work and guides everything we do, ensuring that we deliver life-changing medicines in a responsible way.